:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/DMFV5UX75JCDJGBN6IYN3TORHE.jpg)
European Medicines Agency approves third dose of Pfizer vaccine for people over 18 years of age
The European Medicines Agency approved on Monday a third booster dose of the vaccine against COVID-19 by Pfizer / BioNTech for people over 18 years
pfizer
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/GXYDHHAMWVGWHCFSEGHQBROBYU.jpg)
The European Medicines Agency is studying today the need for the third dose against COVID-19
The experts of the European Medicines Agency (EMA) analyzed this Monday the data provided by the pharmaceutical companies to determine the need for a booster
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/LIYWKQJLQJF6HA3JOTI6TOGCEQ.jpg)
COVID-19 vaccine | What are the side effects of the third dose of Pfizer?
The Centers for Disease Control and Prevention (CDC, in English) ruled out on Tuesday that giving a third dose of the vaccine against the COVID-19
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/3UAY22WMS5DY3LKUXZC2HUS5VI.jpg)
COVID-19 | Pfizer will request authorization to administer its vaccine to children between 5 and 12 years of age in the United States.
Pfizer and BioNTech announced Tuesday that they released initial data on the results of the vaccine against COVID-19 in children between 5 and 12 years
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/AITVXJ3MFNEO7NWRKRKFGAVENE.jpg)
COVID-19 | Pfizer booster dose increased antibody levels 20 times in Sinovac vaccinated
Lima, September 28, 2021Updated on 09/28/2021 11:23 am A booster with the American Pfizer vaccine against the coronavirus increased the level of antibodies up to
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/4GM6HFQZHRDZZB2XPDJMWZXR6A.jpg)
Pfizer Provides US Initial Data on Coronavirus Vaccine in Children Ages 5 to 12
Pfizer and BioNTech announced on Tuesday that they released initial data on the results of the vaccine against coronavirus covid-19 in children between 5 and
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/IZXHIUDIWRCS3LBIX54LXKY4IQ.jpg)
Pfizer Starts Human Trials of Messenger RNA Flu Vaccine
Pfizer reported Monday that it had started the first human trials of a flu vaccine with messenger RNA technology, already used in its vaccine. COVID-19.
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/53VHOM7SWBBHRLHBJSE2MAGCBA.jpg)
COVID-19 | Europe will decide in October whether to authorize Pfizer’s booster dose
The European Medicines Agency reported that it will decide in early October whether or not to approve a third dose of the Pfizer / BioNTech
Pfizer begins testing of a COVID-19 pill
Washington, September 27, 2021Updated on 09/27/2021 12:34 pm US drugmaker Pfizer said Monday it began mid- and late-stage clinical trials of a pill to prevent
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/XPSLM56OLBG7ZKX2CETJXXGP7M.jpg)
Pfizer predicts when the world will return to “normal life” after the pandemic but issues a warning
The CEO of the pharmaceutical company Pfizer, Albert Bourla, predicted this Sunday that in “one year” “normal life” will return after the pandemic of coronavirus
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/GNMG2RL3XZGCTFXO2ELVANULQE.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/7M37AUK3VVHHJLSRV4DTLTVYWE.jpg)
